Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease
Clinical and Experimental Medicine · 29.06.2024 · 24 (1)
DOI: 10.1007/s10238-024-01410-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 29.06.2024. Verfasst von Ying Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, 100029, China. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Kidney Failure, Chronic, Complement C5a, Complement C3a. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, the cross-sectional project of China-Japan Friendship Hospital, International Association of Chinese Nephrologists Research Grant.
Abstract (Originalsprache)
IgA nephropathy (IgAN) is still one of the leading causes of end-stage kidney disease (ESRD), and complement system activation is a key to the pathogenesis of IgAN. The role of complement C3a/C3aR and C5a/C5aR in late stage of IgAN remains unknown. Renal specimens of 75 IgAN patients at the stage 4 CKD were stained using immunofluorescence and immunohistochemistry. The primary outcome was a composite of end-stage renal disease (ESRD) and death. Associations of complement components with baseline clinicopathological characteristics and outcomes were assessed using multivariable Cox regression and Spearman analyses. During a median follow-up of 15.0 months, 27 patients progressed to ESRD and none died. Lower eGFR [hazards ratio (HR), 0.827, 95% confidence interval (CI), 0.732–0.935; P = 0.002] and glomerular C3 deposition (HR, 3.179, 95% CI, 1.079–9.363; P = 0.036) were predictive of time to ESRD in stage 4 CKD IgAN. Higher expression of C3a ( P = 0.010), C3aR ( P = 0.005), C5a ( P = 0.015), and C5aR ( P < 0.001) was identified in ESRD group than in non-ESRD group. Glomerular C3a/C3aR and C5a/C5aR deposits were both correlated with a lower baseline eGFR, higher baseline 24 h-urinary protein (24 h-UP) and faster decline of eGFR. Besides, C3a and C5a deposits were found in patients with high S (S1) and T (T1/2) scores, respectively. Complement C3a/C3aR and C5a/C5aR in IgAN patients with stage 4 CKD may portend a faster deterioration of kidney function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, 100029, China.
- Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, 100029, China. 18810568600@163.com.
- Department of Nephrology, China-Japan Friendship Hospital, No. 2 East Yinghuayuan Street, Chaoyang District, Beijing, 100029, China. wenge_lee2002@126.com.
Förderung
- China Postdoctoral Science Foundation
- the cross-sectional project of China-Japan Friendship Hospital
- International Association of Chinese Nephrologists Research Grant
Zitieren
APA
Wang, Y., Shang, S., Jiang, S., Zou, G., Gao, H., & Li, W. (2024). Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01410-3
Vancouver
Wang Y, Shang S, Jiang S, Zou G, Gao H, Li W. Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01410-3
BibTeX
@article{Wang2024,
author = {Wang, Ying and Shang, Shunlai and Jiang, Shimin and Zou, Guming and Gao, Hongmei and Li, Wenge},
title = {Complement C3a/C3aR and C5a/C5aR deposits accelerate the progression of advanced IgA nephropathy to end-stage renal disease},
journal = {Clinical and Experimental Medicine},
year = {2024},
volume = {24},
number = {1},
doi = {10.1007/s10238-024-01410-3}
}
EUVIMED